Nelson Laboratories announces the opening of a new building it recently acquired adjacent to its current facilities that will accommodate immediate and future requirements for capacity and new capabilities.
"With the new space, you could say we are becoming the campus of Nelson Labs," says Jeffery R. Nelson, president and CEO of Nelson Laboratories. "This building will help us meet the growing testing needs and demands of our clients."
The building will provide increased laboratory and testing space indicating on-going industry and company growth. Much of Nelson's recent growth has been fueled by increased investment in new medical technology, changes in industry guidance and increased regulatory expectations. The testing done at Nelson Laboratories directly supports the development and production of safe medical devices, tissue, drugs, cosmetics and natural products.
The 12,000-square-foot building was renovated to bring it up to Nelson Laboratories' rigorous specifications. The location will be used to add additional sterilizers used in validation testing, aging chambers for packaging testing, and additional space for testing products designed for reuse (e.g., cleaning, disinfection and steam sterilization of tools, kits or scopes used in hospitals).
Established in 1985, Nelson Labs has a strong history of growth in Utah. The company has roughly doubled in size every five years and anticipates the growth trend to continue. Its original facility was 24,000 square feet and was expanded to 62,000 square feet in 2001. In 2010, the company completed a 50,000-square-foot building. With the addition of the newly acquired building, Nelson Labs now has over 122,000 square feet of office and laboratory space.
Â
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.